BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 26980676)

  • 21. Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific Manner.
    Abraham J; Botto S; Mizuno N; Pryke K; Gall B; Boehm D; Sali TM; Jin H; Nilsen A; Gough M; Baird J; Chakhtoura M; Subra C; Trautmann L; Haddad EK; DeFilippis VR
    Front Immunol; 2020; 11():1430. PubMed ID: 32733475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. STING: infection, inflammation and cancer.
    Barber GN
    Nat Rev Immunol; 2015 Dec; 15(12):760-70. PubMed ID: 26603901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular cloning and functional characterization of porcine stimulator of interferon genes (STING).
    Xie L; Liu M; Fang L; Su X; Cai K; Wang D; Chen H; Xiao S
    Dev Comp Immunol; 2010 Aug; 34(8):847-54. PubMed ID: 20346968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impaired STING Pathway in Human Osteosarcoma U2OS Cells Contributes to the Growth of ICP0-Null Mutant Herpes Simplex Virus.
    Deschamps T; Kalamvoki M
    J Virol; 2017 May; 91(9):. PubMed ID: 28179534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The host STING pathway at the interface of cancer and immunity.
    Corrales L; McWhirter SM; Dubensky TW; Gajewski TF
    J Clin Invest; 2016 Jul; 126(7):2404-11. PubMed ID: 27367184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytosolic sensing of aberrant DNA: arming STING on the endoplasmic reticulum.
    Wang Q; Liu X; Zhou Q; Wang C
    Expert Opin Ther Targets; 2015; 19(10):1397-409. PubMed ID: 26220155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Balancing STING in antimicrobial defense and autoinflammation.
    Landman SL; Ressing ME; van der Veen AG
    Cytokine Growth Factor Rev; 2020 Oct; 55():1-14. PubMed ID: 32563552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Critical Role for STING Signaling in Limiting Pathogenesis of Chikungunya Virus.
    Geng T; Lin T; Yang D; Harrison AG; Vella AT; Fikrig E; Wang P
    J Infect Dis; 2021 Jun; 223(12):2186-2196. PubMed ID: 33161431
    [TBL] [Abstract][Full Text] [Related]  

  • 29. STING agonists induce an innate antiviral immune response against hepatitis B virus.
    Guo F; Han Y; Zhao X; Wang J; Liu F; Xu C; Wei L; Jiang JD; Block TM; Guo JT; Chang J
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1273-81. PubMed ID: 25512416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evasion of the STING DNA-Sensing Pathway by VP11/12 of Herpes Simplex Virus 1.
    Deschamps T; Kalamvoki M
    J Virol; 2017 Aug; 91(16):. PubMed ID: 28592536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of Duck Tembusu Virus Nonstructural Protein 2A to Duck STING Disrupts Induction of Its Signal Transduction Cascade To Inhibit Beta Interferon Induction.
    Zhang W; Jiang B; Zeng M; Duan Y; Wu Z; Wu Y; Wang T; Wang M; Jia R; Zhu D; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Liu Y; Zhang L; Yu Y; Pan L; Chen S; Cheng A
    J Virol; 2020 Apr; 94(9):. PubMed ID: 32075929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TICAM-1 is dispensable in STING-mediated innate immune responses in myeloid immune cells.
    Takashima K; Oshiumi H; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2018 May; 499(4):985-991. PubMed ID: 29627569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. STING and TRIF Contribute to Mouse Sepsis, Depending on Severity of the Disease Model.
    Heipertz EL; Harper J; Walker WE
    Shock; 2017 May; 47(5):621-631. PubMed ID: 27755506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promising Targets for Cancer Immunotherapy: TLRs, RLRs, and STING-Mediated Innate Immune Pathways.
    Li K; Qu S; Chen X; Wu Q; Shi M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28216575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diminished stimulator of interferon genes production with cigarette smoke-exposure contributes to weakened anti-adenovirus vectors response and destruction of lung in chronic obstructive pulmonary disease model.
    Qin H; Huang G; Gao F; Huang B; Wang D; Hu X; Wang Y; Peng L; Luo D; Mo B; Hu C; Li Y; Wang C
    Exp Cell Res; 2019 Nov; 384(1):111545. PubMed ID: 31470016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
    Iurescia S; Fioretti D; Rinaldi M
    Recent Pat Anticancer Drug Discov; 2018; 13(1):2-17. PubMed ID: 29086701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MITA/STING-mediated antiviral immunity and autoimmunity: the evolution, mechanism, and intervention.
    Zhong B; Shu HB
    Curr Opin Immunol; 2022 Oct; 78():102248. PubMed ID: 36193584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yersinia YopJ negatively regulates IRF3-mediated antibacterial response through disruption of STING-mediated cytosolic DNA signaling.
    Cao Y; Guan K; He X; Wei C; Zheng Z; Zhang Y; Ma S; Zhong H; Shi W
    Biochim Biophys Acta; 2016 Dec; 1863(12):3148-3159. PubMed ID: 27742471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PTPN1/2-mediated dephosphorylation of MITA/STING promotes its 20S proteasomal degradation and attenuates innate antiviral response.
    Xia T; Yi XM; Wu X; Shang J; Shu HB
    Proc Natl Acad Sci U S A; 2019 Oct; 116(40):20063-20069. PubMed ID: 31527250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HTLV-1 Tax impairs K63-linked ubiquitination of STING to evade host innate immunity.
    Wang J; Yang S; Liu L; Wang H; Yang B
    Virus Res; 2017 Mar; 232():13-21. PubMed ID: 28119118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.